Though guidelines suggest screening starts at 50, researcher says it's premature to change them
by willem on Fri Nov 30, 2012 08:46 PM
I was diagnosed with AML on May 6th 2011 and was hospitalised on the 8th of May. My AML was too far for undergoing conventional treatment and the hospital invited me to join a French research programme "Chemotherapy induction type LIA,LAMSA maintenance REV 5AZA"
Now some 20 months later, the treatment failed and the Medical team here in France proposes an other research programme, based on Vosaroxin, a study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory Acute Myeloid Leukemia (AML)
Does anybody has any experience with this kind of research programme??
by SusanLB_1 on Sat Dec 01, 2012 03:30 AM
by willem on Tue Dec 18, 2012 01:37 PM
On déc. 01, 2012 3:30 SusanLB_1 wrote: I don't think I would try anything if there was a chance of getting a placebo. What are your blasts? Do they want you to go back into remission so they can do a transplant?
On déc. 01, 2012 3:30 SusanLB_1 wrote:
Donot know about the blasts and I don't think they will do a transplant at the age of 66.
by SusanLB_1 on Tue Dec 18, 2012 02:15 PM
by willem on Tue Dec 18, 2012 08:01 PM
I am 66, born february 1946
by willem on Wed Dec 19, 2012 07:30 AM
I found the Website whith the protocal of the research programme:
Hope to hear from you soon.
by albina on Thu Mar 07, 2013 03:21 PM
My mother has started on Vosaroxin trial that you mentioned below. It has 2 arms: control arm with cytarabine intermediate dose plus placebo and test arm with same cytarabine plus vosaroxin. Anyone who is participating is getting cytarabine intermediate dose and may or may not get the new drug.
Cytarabine intermediate dose is not the best approach to put someone in remission as there are some other agents (e.g., 7+3 or MEC protocol for when 7+3 didn't work). However, I guess because of my mom's age, intermediate dose of cytarabine would be the most she can handle, that is why trial was not a bad option for her.
She is 74. She is Russian but got sick in the US while visiting me. She may be a candidate for a transplant and had a consult; which raised some eyebrows when we mentioned to Russian doctors. Will see where this treatment takes us.
Good luck to you
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
We care about your feedback. Let us know how we can improve your CancerCompass experience.